Triple reuptake inhibitors and methods of their use

Details for Australian Patent Application No. 2009330355 (hide)

Owner Sunovion Pharmaceuticals Inc.

Inventors Shao, Liming; Wang, Fengjiang; Malcolm, Scott C.; Hewitt, Michael C.

Agent HENRY HUGHES LIMITED

Pub. Number AU-A-2009330355

PCT Pub. Number WO2010/075064

Priority 61/138,062 16.12.08 US

Filing date 15 December 2009

Wipo publication date 1 July 2010

International Classifications

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 209/52 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

27 October 2011 Section 223 Application Allowed

  Sepracor Inc. The time in which to enter the National Phase has been extended to 16 Sep 2011. Address for service in Australia - HENRY HUGHES LIMITED Henry Hughes c/- PO Box 286 Carlton North VIC 3054 2010 Extensions of Time, Section 223

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/075064 Priority application(s): WO2010/075064

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009330365-Protein kinase inhibitors

2009330353-Setting tool for expandable liner hanger and associated methods